Navigation Links
Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
Date:1/24/2011

THOUSAND OAKS, Calif. and WOBURN, Mass., Jan. 24, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Group, Inc. today announced that the companies have entered into a definitive acquisition agreement under which Amgen has agreed to acquire BioVex Group, Inc., a privately held, venture-funded,  biotechnology company headquartered in Woburn, Mass. BioVex is developing OncoVEX(GM-CSF), a novel oncolytic vaccine in Phase 3 clinical development, that may represent a new approach to treating melanoma and head and neck cancer.

Under terms of the agreement, Amgen will pay up to $1 billion: $425 million in cash at closing and up to $575 million in additional payments upon the achievement of certain regulatory and sales milestones.  The transaction has been approved by the boards of directors of each company.  It is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2011.  Following the completion of the transaction, BioVex will become a wholly owned subsidiary of Amgen.  

"OncoVex has demonstrated encouraging anti-tumor activity in clinical studies for the treatment of melanoma and head and neck cancer, and BioVex is currently enrolling patients into pivotal Phase 3 trials in both indications," said Roger M. Perlmutter, M.D., Ph.D., Amgen's executive vice president, Research and Development.  "Amgen is particularly excited about joining with BioVex and its talented staff to focus on advancing this late-stage investigational therapy, with the hope of bringing it to market within the next few years."

"Amgen is ideally positioned to leverage the potential of OncoVEX in multiple solid tumor indications given their impressive oncology franchise and expertise in biologics manufacturing and development," said Philip Astley-Sparke, chi
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amgen and Xencor Enter Option Deal to Co-Develop Xencors Novel Antibody for Autoimmune Diseases
2. Call for Applications: The Amgen Award for Science Teaching Excellence
3. Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
4. Amgen to Provide Testimony at FDA Hearing on Biosimilars
5. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
6. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
7. Array BioPharma and Amgen Partner in Type 2 Diabetes
8. Amgen to Present at Lazard Capital Healthcare Conference
9. Amgen Announces Webcast of 2009 Third Quarter Financial Results
10. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
11. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., a ... and therapeutics, announced today that StemCyte has become an ... car driven by James Jakes . ... 2013 season.   StemCyte, Inc. and Rahal Letterman ... umbilical cord blood banking and its educational initiative ,Stars ...
(Date:5/23/2013)... 23, 2013 PI’s new LPS-24 ... provide 15 mm travel range with closed-loop sensor ... dimensions make these new positioners the ideal choice ... vacuum rated version is also available. , ... datasheets can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
(Date:5/23/2013)... 2013  Saddleback Memorial Medical Center in ... hospital on the West Coast to perform a hysterectomy ... provides women with a state-of-the-art, minimally invasive approach to ... , M.D., a highly regarded Orange ... of minimally invasive surgery at Saddleback Memorial, led the ...
(Date:5/23/2013)... May 23, 2013 BioTrends Research Group, ... firms for specialized biopharmaceutical issues, finds that, unaided, ... disease specialists reported that in the past six ... delaying treatment) in anticipation of the next generation ... ago, when only 6 percent reported that they ...
Breaking Biology Technology:StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
... Research has shown that certain marginalized groups including ... as African Americans and Latinos fare worse than ... impoverishment, injuries and fatalities. , Now, ... found that they also experience greater terrorism-related fears and ...
... the media. A new study by Dr. Yaniv Levyatan ... of Israel,s National Security College, describes how our side ... , "Information warfare" plays a crucial role in ... conventional weapons. Therefore, the information warfare against terrorist organizations ...
... discovered a way to use an ancient life form to ... systems that may be surprisingly simple to build compared to ... tiny, single-celled marine life forms have existed for at least ... the life in the oceans, but they also have rigid ...
Cached Biology Technology:Disabled and other vulnerable groups more susceptible to terrorism fears 2Information warfare in the 21st century: Ideas are sometimes stronger than bombs 2Ancient diatoms lead to new technology for solar energy 2
(Date:5/23/2013)... Science , Automated conserved noncoding ... promoter evolution among grasses , Within the genome ... DNA that undergo little change in position and sequence ... any proteins. Some of these evolutionarily stable sequences, so-called ... expression of other genes or the condensation of chromosomes, ...
(Date:5/23/2013)... discovering the new mechanism by which estrogen suppresses lipid ... a potential new approach toward treating certain liver diseases. ... colleagues believe they are changing long-held views in the ... of the journal Science Signaling . , "The ... has been that only receptors located in the nucleus ...
(Date:5/23/2013)... in treating cerebral palsy with autologous cord blood. Following ... year old boy had been in a persistent vegetative ... months after treatment with the cord blood containing stem ... the child learned to speak simple sentences and to ... study, dispel the long-held doubts about the effectiveness of ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2First successful treatment of pediatric cerebral palsy with autologous cord blood 2
... discovered a gene that may provide a clue as to ... published today in the Proceedings of the National Academy ... of Kevin Wickman, Ph.D., associate professor of pharmacology at the ... mice as part of an ongoing study to understand how ...
... Commonwealth Health Minister,s Award for Excellence in Health and ... award from the Parliamentary Secretary for Defence Support, Dr ... Society for Medical Research dinner, one of the highlights ... an internationally renowned scientist who has completed their PhD ...
... Total fat intake and dinner fat intake seem to influence ... research abstract that will be presented on Tuesday at SLEEP ... Societies (APSS). The study, authored by Cibele Crispim, of ... 52 healthy volunteers between 20-45 years of age, whose food ...
Cached Biology News:Monash researcher receives prestigious Commonwealth Health Minister's award 2Fat intake negatively influences the sleep pattern in healthy adults 2
... is designed to allow ampicillin selection in ... driving the gene for ampicillin resistance is ... promoter. It mediates higher transcription efficiency than ... polyadenylation signal terminates the ampicillin expression. The ...
... The PRO S-7 stirrers deliver ... housing channels fluids away from ... features easy-to-use controls which allow ... 7"x7" ceramic tops feature a ...
... The loxP-cm-loxP cassette ... in prokaryotic cells. The prokaryotic ... chloramphenicol resistance is a slightly modified ... mediates higher transcription efficiency than the ...
... the fast and simple integration of loxP-sites ... (for the generation of transgenic mouse models). ... allow neomycin / kanamycin selection in prokaryotic ... promoter (gb2) for expression of kanamycin resistance ...
Biology Products: